CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/112_2020_35
Reference206 articles.
1. Al-Toub M, Almohawes M, Vishnubalaji R, Alfayez M, Aldahmash A, Kassem M et al (2019) CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors. Cell Death Discov 5:87
2. Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ et al (2014) International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 66(1):1–79
3. Bai M, Zheng Y, Liu H, Su B, Zhan Y, He H (2017) CXCR5(+) CD8(+) T cells potently infiltrate pancreatic tumors and present high functionality. Exp Cell Res 361(1):39–45
4. Baugher PJ, Richmond A (2008) The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis. J Biol Chem 283(45):30868–30878
5. Becker JH, Gao Y, Soucheray M, Pulido I, Kikuchi E, Rodriguez ML et al (2019) CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC. Cancer Res 79(17):4439–4452
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Screening of the shared pathogenic genes of ulcerative colitis and colorectal cancer by integrated bioinformatics analysis;Journal of Cellular and Molecular Medicine;2023-07-26
2. Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity;Clinical and Translational Oncology;2023-04-19
3. Screening of pathogenic genes of ulcerative colitis and colorectal cancer by integrated bioinformatics analysis;2023-03-29
4. High expression of CXCL9 gene promotes immune invasion and improves the prognosis of patients with endometrial cancer;2023-01-10
5. Small molecule-based immunomodulators for cancer therapy;Acta Pharmaceutica Sinica B;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3